Professor Anthony Chalmers

Chair of Clinical Oncology (Clinical Research Garscube)

telephone: 01413306426
email: Anthony.Chalmers@glasgow.ac.uk

Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, Garscube Estate, Glasgow, G61 1QH

Research interests

Glioblastoma is the commonest and most aggressive primary brain tumour and is often refractory to conventional cancer treatments. The ultimate aim of our research group is to improve outcomes for patients with these tumours by overcoming their inherent resistance to radiotherapy and chemotherapy.

Much of our work has focused on the DNA repair protein poly(ADP-ribose) polymerase, commonly known as PARP. Drugs that inhibit PARP increase the sensitivity of tumour cells to radiotherapy and to chemotherapy agents such as temozolomide. We are currently developing a series of clinical trials to test whether PARP inhibitors can be safely and effectively combined with radiotherapy and chemotherapy in patients with glioblastoma.

Current and future work will also investigate the effect of the tumour microenvironment on radiation responses of glioblastoma cells. In order to do this we are developing a novel in vitro cell culture system that recapitulates some of the key features of the glioblastoma microenvironment.

Biography

Research groups

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Number of items: 104.

2024

Williamson, Aoife, Houston, Peter, Paterson, Jennifer, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Fullerton, Natasha, Foo, Sin Yee, James, Allan ORCID: https://orcid.org/0000-0003-4472-7095 and Nowicki, Stefan (2024) Dosimetric comparison of hippocampal sparing technologies in patients with low grade glioma. Neuro-Oncology Advances, 6(1), vdae131. (doi: 10.1093/noajnl/vdae131) (PMID:39220244) (PMCID:PMC11364934)

Jackson, Mark R., Richards, Amanda R., Oladipupo, Abdul-Basit Ayoola, Chahal, Sandeep K., Caragher, Seamus, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Gomez-Roman, Natividad (2024) ClonoScreen3D - a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma. International Journal of Radiation Oncology, Biology, Physics, 120(1), pp. 162-177. (doi: 10.1016/j.ijrobp.2024.02.046) (PMID:38493899)

Boele, F. et al. (2024) Inequalities in access to neuro-oncology supportive care and rehabilitation: a survey of healthcare professionals’ perspectives. Neuro-Oncology Practice, 11(4), pp. 484-493. (doi: 10.1093/nop/npae023) (PMID:39006521)

Lorimer, Cressida, Mills, Samantha, Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278, Coombes, Isobelle, Thompson, Gerard, Glendenning, Jennifer, Radon, Mark, Jones, Christopher, Williamson, Aoife and Brock, Juliet (2024) Baseline total brain volume predicts changes in quality of life and overall survival after cranial radiotherapy in older patients with glioblastoma: Results from the prospective BRITER study. Neuro-Oncology Practice, 11(4), pp. 413-420. (doi: 10.1093/nop/npae019) (PMID:39006523)

Werner, Jan-Michael, Petrescu, George E.D., Boele, Florien, Preusser, Matthias, Platten, Michael, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Short, Susan C. and Piil, Karin (2024) Chairing scientific sessions at international Neuro-Oncology meetings: an EANO guide for early-career professionals. Neuro-Oncology Practice, (doi: 10.1093/nop/npae060) (Early Online Publication)

Derby, S. et al. (2024) Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)

Wakeham, Katie, Cooper, Tim, Rowbottom, Carl, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Price, Pat, Quinlan, Sarah and Spencer, Katie (2024) Towards world-class radiotherapy in the UK: time for transformation. Lancet Oncology, 25(4), pp. 418-419. (doi: 10.1016/S1470-2045(24)00103-7) (PMID:38408465)

Derby, S. et al. (2024) Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial. International Journal of Radiation Oncology, Biology, Physics, 118(5), pp. 1371-1378. (doi: 10.1016/j.ijrobp.2024.01.011) (PMID:38211641)

Tesson, Mathias, Stevenson, Katrina, Karim, Saadia A., Nixon, Colin, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Sansom, Owen J., O'Neill, Eric, Jones, Keaton and Morton, Jennifer P. ORCID: https://orcid.org/0000-0001-5766-9141 (2024) Targeted irradiation in an autochthonous mouse model of pancreatic cancer. Disease Models and Mechanisms, 17(3), dmm050463. (doi: 10.1242/dmm.050463) (PMID:38421046) (PMCID:PMC10958199)

Derby, S. et al. (2024) Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalisation via macropinocytosis. Neuro-Oncology, (doi: 10.1093/neuonc/noad210) (PMID:37936324) (Early Online Publication)

2023

Kouli, O. Omar, McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Morrison, David, Zaorsky, Nicholas G. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2023) Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours. Clinical and Translational Radiation Oncology, 42, 100658. (doi: 10.1016/j.ctro.2023.100658) (PMID:37502698) (PMCID:PMC10368762)

Verhaegen, F. et al. (2023) Roadmap for precision preclinical x-ray radiation studies. Physics in Medicine and Biology, 68(6), 06RM01. (doi: 10.1088/1361-6560/acaf45) (PMID:36584393)

Grocutt, L., Rutherford, A., Caldwell, D., Wilkinson, C., Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278, Dempsey, L., Kelly, C. ORCID: https://orcid.org/0000-0002-5330-7888 and O'Cathail, S.M. ORCID: https://orcid.org/0000-0001-5574-9199 (2023) The impact of COVID-19 on radiotherapy services in Scotland, UK: a population-based study. Clinical Oncology, 35(2), e227-e234. (doi: 10.1016/j.clon.2022.11.018) (PMID:36528474) (PMCID:PMC9708615)

Koessinger, D. et al. (2023) Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness. Neuro-Oncology Advances, 5(1), vdad067. (doi: 10.1093/noajnl/vdad067) (PMID:37334166) (PMCID:PMC10276538)

2022

O'Cathail, S.M. ORCID: https://orcid.org/0000-0001-5574-9199 and Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2022) Integrating novel cancer therapies with radiation - illuminating the tunnel. Clinical Oncology, 35(1), pp. 38-41. (doi: 10.1016/j.clon.2022.10.010) (PMID:36333159)

Falcone, M. et al. (2022) Sensitisation of cancer cells to radiotherapy by serine and glycine starvation. British Journal of Cancer, 127(10), pp. 1773-1786. (doi: 10.1038/s41416-022-01965-6) (PMID:36115879) (PMCID:PMC9643498)

Koessinger, A. L. et al. (2022) Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics. Cell Death and Differentiation, 29(10), pp. 2089-2104. (doi: 10.1038/s41418-022-01001-3) (PMID:35473984) (PMCID:PMC9525582)

McAleavey, Patrick G., Walls, Gerard M. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2022) Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review. CNS Oncology, 11(2), CNS86. (doi: 10.2217/cns-2021-0015) (PMID:35603818) (PMCID:PMC9134931)

Willers, Henning, Krause, Mechthild, Faivre-Finn, Corinne and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2022) Targeting PARP for chemoradiosensitization: opportunities, challenges, and the road ahead. International Journal of Radiation Oncology, Biology, Physics, 112(2), pp. 265-270. (doi: 10.1016/j.ijrobp.2021.10.142) (PMID:34998527)

Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)

Aiyappa-Maudsley, Radhika, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Parsons, Jason L. (2022) Factors affecting the radiation response in glioblastoma. Neuro-Oncology Advances, 4(1), vdac156. (doi: 10.1093/noajnl/vdac156) (PMID:36325371) (PMCID:PMC9617255)

Derby, Sarah J. ORCID: https://orcid.org/0000-0003-0040-0410, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Carruthers, Ross ORCID: https://orcid.org/0000-0003-1077-6120 (2022) Radiotherapy-poly(ADP-ribose) polymerase inhibitor combinations: progress to date. Seminars in Radiation Oncology, 32(1), pp. 15-28. (doi: 10.1016/j.semradonc.2021.09.005) (PMID:34861992)

Gutierrez-Quintana, Rodrigo ORCID: https://orcid.org/0000-0002-3570-2542, Walker, David J. ORCID: https://orcid.org/0000-0002-3600-1406, Williams, Kaye J., Forster, Duncan M. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2022) Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors? Neuro-Oncology Advances, 4(1), vdab190. (doi: 10.1093/noajnl/vdab190) (PMID:35118383) (PMCID:PMC8807076)

2021

Birch, J. et al. (2021) Inhibition of ATR prevents macropinocytosis driven retraction of neurites and opposes invasion in GBM. Research Square, (doi: 10.21203/rs.3.rs-967109/v1) (PMID:37936324)

Tsim, S. et al. (2021) Serum proteomics and plasma fibulin-3 in differentiation of mesothelioma from asbestos-exposed controls and patients with other pleural diseases. Journal of Thoracic Oncology, 16(10), pp. 1705-1717. (doi: 10.1016/j.jtho.2021.05.018) (PMID:34116230) (PMCID:PMC8514249)

Koessinger, A. L. et al. (2021) Increased apoptotic priming of glioblastoma enables therapeutic targeting by BH3-mimetics. bioRxiv, (doi: 10.1101/2021.06.13.448232)

Nile, Donna L., Rae, Colin ORCID: https://orcid.org/0000-0003-4432-6670, Walker, David J. ORCID: https://orcid.org/0000-0002-3600-1406, Canning Waddington, Joe, Vincent, Isabel ORCID: https://orcid.org/0000-0003-2663-4389, Burgess, Karl, Gaze, Mark N., Mairs, Robert J. ORCID: https://orcid.org/0000-0001-6843-3900 and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2021) Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells. Cancer and Metabolism, 9, 24. (doi: 10.1186/s40170-021-00258-5) (PMID:34011385) (PMCID:PMC8136224)

Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 and Carruthers, R.D. ORCID: https://orcid.org/0000-0003-1077-6120 (2021) Radiobiology summaries: DNA damage and repair. Clinical Oncology, 33(5), pp. 275-278. (doi: 10.1016/j.clon.2020.12.006) (PMID:33341330)

Hanna, Catherine R. ORCID: https://orcid.org/0000-0002-0907-7747, Robb, Kathryn A. ORCID: https://orcid.org/0000-0002-1672-0411, Blyth, Kevin G. ORCID: https://orcid.org/0000-0003-2972-6641, Jones, Robert J. ORCID: https://orcid.org/0000-0002-2904-6980 and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2021) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, 109(4), pp. 886-890. (doi: 10.1016/j.ijrobp.2020.12.003) (PMID:33309910) (PMCID:PMC7726525)

Rulach, R. et al. (2021) An international expert survey on the indications and practice of radical thoracic reirradiation for non-small cell lung cancer. Advances in Radiation Oncology, 6(2), 100653. (doi: 10.1016/j.adro.2021.100653) (PMID:33851065) (PMCID:PMC8022147)

Liu, Q. et al. (2021) Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. Science Translational Medicine, 13(580), eabc4465. (doi: 10.1126/scitranslmed.abc4465) (PMID:33568520)

Al-mubarak, H., Vallatos, A. ORCID: https://orcid.org/0000-0002-5202-056X, Gallagher, L., Birch, J. ORCID: https://orcid.org/0000-0001-9522-8435, Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 and Holmes, W.M. ORCID: https://orcid.org/0000-0002-0942-215X (2021) Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma. Magnetic resonance imaging, 85, pp. 121-127. (doi: 10.1016/j.mri.2021.10.030) (PMID:34687852)

Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E. and Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2021) Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe COVID-19 lung disease. Clinical Oncology, 33(1), e64-e68. (doi: 10.1016/j.clon.2020.08.003) (PMID:32829986) (PMCID:PMC7427522)

2020

Hanna, C. et al. (2020) Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-Oncology, 22(12), pp. 1840-1850. (doi: 10.1093/neuonc/noaa104) (PMID:32347934) (PMCID:PMC7746945)

Koessinger, Anna L., Koessinger, Dominik, Stevenson, Katrina, Cloix, Catherine, Mitchell, Louise, Nixon, Colin, Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Norman, Jim C. ORCID: https://orcid.org/0000-0002-0098-3014 and Tait, Stephen W.G. ORCID: https://orcid.org/0000-0001-7697-132X (2020) Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts. Scientific Reports, 10, 15361. (doi: 10.1038/s41598-020-72322-x) (PMID:32958777) (PMCID:PMC7506024)

Rae, Colin ORCID: https://orcid.org/0000-0003-4432-6670, Fragkoulis, George I. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2020) Cytotoxicity and radiosensitizing activity of the fatty acid synthase inhibitor C75 is enhanced by blocking fatty acid uptake in prostate cancer cells. Advances in Radiation Oncology, 5(5), pp. 944-1005. (doi: 10.1016/j.adro.2020.06.022) (PMID:33083663) (PMCID:PMC7557210)

Litchfield, K. et al. (2020) Representative sequencing: unbiased sampling of solid tumor tissue. Cell Reports, 31(5), 107550. (doi: 10.1016/j.celrep.2020.107550) (PMID:32375028)

Jackson, Mark R. ORCID: https://orcid.org/0000-0003-3843-2995, Ashton, Miranda, Koessinger, Anna L., Dick, Craig, Verheij, Marcel and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2020) Mesothelioma cells depend on the anti-apoptotic protein Bcl-xL for survival and are sensitized to ionizing radiation by BH3-mimetics. International Journal of Radiation Oncology, Biology, Physics, 106(4), pp. 867-877. (doi: 10.1016/j.ijrobp.2019.11.029) (PMID:31786278)

Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, Chong, Ming Y., Chahal, Sandeep K., Caragher, Seamus P., Jackson, Mark R. ORCID: https://orcid.org/0000-0003-3843-2995, Stevenson, Katrina H., Dongre, Sidhartha A. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2020) Radiation responses of 2D and 3D glioblastoma cells: a novel, 3D-specific radioprotective role of VEGF/Akt signaling through functional activation of NHEJ. Molecular Cancer Therapeutics, 19(2), pp. 575-589. (doi: 10.1158/1535-7163.MCT-18-1320) (PMID:31672763)

Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278, Chan, C. and Sebag-Montefiore, D. (2020) CTRad 10 years on: from 10-point plan to top 10 achievements. Clinical Oncology, 32(1), pp. 9-12. (doi: 10.1016/j.clon.2019.09.043) (PMID:31543302)

2019

Beckta, Jason M., Bindra, Ranjit S. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2019) Targeting DNA repair in gliomas. Current Opinion in Neurology, 32(6), pp. 878-885. (doi: 10.1097/WCO.0000000000000760) (PMID:31592790)

Chong, Ming Yao, Lorimer, Cressida F., Mehta, Shaveta, Ibrahim, Ehab, Brock, Juliet, McBain, Catherine, McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700 and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2019) An audit of the management of elderly patients with glioblastoma in the UK: have recent trial results changed treatment? CNS Oncology, 8(4), CNS47. (doi: 10.2217/cns-2019-0017) (PMID:31818127) (PMCID:PMC6974914)

Al-Mubarak, H., Vallatos, A. ORCID: https://orcid.org/0000-0002-5202-056X, Gallagher, L., Birch, J. ORCID: https://orcid.org/0000-0001-9522-8435, Gilmour, L., Foster, J., Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 and Holmes, W.M. ORCID: https://orcid.org/0000-0002-0942-215X (2019) Stacked in-plane histology for quantitative validation of non-invasive imaging biomarkers: application to an infiltrative brain tumour model. Journal of Neuroscience Methods, 326, 108372. (doi: 10.1016/j.jneumeth.2019.108372) (PMID:31348965)

Venkataramani, V. et al. (2019) Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature, 573(7775), pp. 532-538. (doi: 10.1038/s41586-019-1564-x) (PMID:31534219)

Palma, D. A. et al. (2019) Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial. BMC Cancer, 19(1), 816. (doi: 10.1186/s12885-019-5977-6) (PMID:31426760) (PMCID:PMC6699121)

Vallatos, A. ORCID: https://orcid.org/0000-0002-5202-056X, Al-Mubarak, H.F.I., Birch, J.L. ORCID: https://orcid.org/0000-0001-9522-8435, Gallagher, L., Mullin, J.M., Gilmour, L., Holmes, W.M. ORCID: https://orcid.org/0000-0002-0942-215X and Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2019) Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region. Journal of Magnetic Resonance Imaging, 50(2), pp. 529-540. (doi: 10.1002/jmri.26580) (PMID:30569620)

Kokurewicz, K. et al. (2019) Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements. Scientific Reports, 9, 10837. (doi: 10.1038/s41598-019-46630-w) (PMID:31346184) (PMCID:PMC6658670)

Gomez-Roman, Natividad and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2019) Patient-specific 3D-printed glioblastomas. Nature Biomedical Engineering, 3, pp. 498-499. (doi: 10.1038/s41551-019-0379-2) (PMID:31148599)

Gobin, M. et al. (2019) A DNA repair and cell cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications. Cancer Research, 79(6), pp. 1226-1238. (doi: 10.1158/0008-5472.CAN-18-2076) (PMID:30674534)

Caragher, Seamus, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Gomez-Roman, Maria ORCID: https://orcid.org/0000-0002-2325-7517 (2019) Glioblastoma's next top model: novel culture systems for brain cancer radiotherapy research. Cancers, 11(1), 44. (doi: 10.3390/cancers11010044) (PMID:30621226) (PMCID:PMC6356812)

Rutherford, Alasdair, Stevenson, Katrina, Tulk, Amanda and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2019) Evaluation of four different small animal radiation plans on tumour and normal tissue dosimetry in a glioblastoma mouse model. British Journal of Radiology, 92(1095), 20180469. (doi: 10.1259/bjr.20180469) (PMID:30362815) (PMCID:PMC6541187)

2018

Birch, J. L. et al. (2018) A novel small-molecule inhibitor of MRCK prevents radiation-driven invasion in glioblastoma. Cancer Research, 78(22), pp. 6509-6522. (doi: 10.1158/0008-5472.CAN-18-1697) (PMID:30279244)

Sharma, R. A. et al. (2018) Clinical development of new drug–radiotherapy combinations. Nature Reviews Clinical Oncology, 13(10), pp. 627-642. (doi: 10.1038/nrclinonc.2016.79) (PMID:27245279)

Carruthers, R. D. et al. (2018) Replication stress drives constitutive activation of the DNA damage response and radioresistance in glioblastoma stem-like cells. Cancer Research, 78(17), pp. 5060-5071. (doi: 10.1158/0008-5472.CAN-18-0569) (PMID:29976574) (PMCID:PMC6128404)

Martinez-Zubiaurre, Inigo, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Hellevik, Turid (2018) Radiation-induced transformation of immunoregulatory networks in the tumor stroma. Frontiers in Immunology, 9, 1679. (doi: 10.3389/fimmu.2018.01679) (PMID:30105016) (PMCID:PMC6077256)

Martin, Geoffrey A. ORCID: https://orcid.org/0000-0002-7533-8466, Tsim, Selina, Kidd, Andrew C., Foster, John E., McLoone, Philip ORCID: https://orcid.org/0000-0003-0002-8700, Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 and Blyth, Kevin G. ORCID: https://orcid.org/0000-0003-2972-6641 (2018) Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respiratory Research, 5(1), e000293. (doi: 10.1136/bmjresp-2018-000293) (PMID:29862030) (PMCID:PMC5976095)

Zmuda, Filip, Blair, Adele, Liuzzi, Maria Clara, Malviya, Gaurav ORCID: https://orcid.org/0000-0003-0736-7991, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Lewis, David, Sutherland, Andrew ORCID: https://orcid.org/0000-0001-7907-5766 and Pimlott, Sally L. ORCID: https://orcid.org/0000-0002-8396-3392 (2018) An 18F-labeled poly(ADP-ribose) polymerase positron emission tomography imaging agent. Journal of Medicinal Chemistry, 61(9), pp. 4103-4114. (doi: 10.1021/acs.jmedchem.8b00138) (PMID:29630818) (PMCID:PMC6007963)

Gray, E. et al. (2018) Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios. BMJ Open, 8(5), e017593. (doi: 10.1136/bmjopen-2017-017593) (PMID:29794088) (PMCID:PMC5988134)

Holmes, William M. ORCID: https://orcid.org/0000-0002-0942-215X, Vallatos, Antoine ORCID: https://orcid.org/0000-0002-5202-056X, Gilmour, Lesley and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2018) Multiple boli arterial spin labelling for high signal-to-noise rodent brain perfusion imaging. Magnetic Resonance in Medicine, 79(2), pp. 1020-1030. (doi: 10.1002/mrm.26706) (PMID:28516482)

Ashton, M. et al. (2018) SYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma. Clinical and Translational Radiation Oncology, 8, pp. 45-49. (doi: 10.1016/j.ctro.2017.11.004)

Fulton, B. et al. (2018) PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status. Clinical and Translational Radiation Oncology, 8, pp. 12-16. (doi: 10.1016/j.ctro.2017.11.003)

Thompson, Mareike K., Poortmans, Philip, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Faivre-Finn, Corinne, Hall, Emma, Huddart, Robert A., Lievens, Yolande, Sebag-Montefiore, David and Coles, Charlotte E. (2018) Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? British Journal of Cancer, 119, pp. 389-407. (doi: 10.1038/s41416-018-0201-z) (PMID:30061587) (PMCID:PMC6117262)

2017

Lorimer, C.F., Hanna, C. ORCID: https://orcid.org/0000-0002-0907-7747, Saran, F., Chalmers, A. ORCID: https://orcid.org/0000-0002-1746-7278 and Brock, J. (2017) Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology, 29(11), pp. 739-747. (doi: 10.1016/j.clon.2017.05.010) (PMID:28807361)

Ashton, Miranda, O'Rourke, Noelle, Currie, Suzanne, Rimner, Andreas and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2017) The role of radical radiotherapy in the management of malignant pleural mesothelioma: a systematic review. Radiotherapy and Oncology, 125(1), pp. 1-12. (doi: 10.1016/j.radonc.2017.08.003) (PMID:28859932)

Bindra, Ranjit S., Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Evans, Sydney and Dewhirst, Mark (2017) GBM radiosensitizers: dead in the water…or just the beginning? Journal of Neuro-Oncology, 134(3), pp. 513-521. (doi: 10.1007/s11060-017-2427-7) (PMID:28762004)

Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, Stevenson, Katrina, Gilmour, Lesley, Hamilton, Graham and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2017) A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses. Neuro-Oncology, 19(2), pp. 229-241. (doi: 10.1093/neuonc/now164) (PMID:27576873) (PMCID:PMC5463789)

Paterson, C. et al. (2017) Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study. Clinical and Translational Radiation Oncology, 2, pp. 13-18. (doi: 10.1016/j.ctro.2016.12.003)

Carruthers, Ross ORCID: https://orcid.org/0000-0003-1077-6120 and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2017) Improving the therapeutic ratio of radiotherapy by targeting the DNA damage response. In: Tofilon, Philip J. and Camphausen, Kevin (eds.) Increasing the Therapeutic Ratio of Radiotherapy. Series: Cancer drug discovery and development. Humana Press: Cham, Switzerland, pp. 1-34. ISBN 9783319408521 (doi: 10.1007/978-3-319-40854-5_1)

2016

Kaur, A. et al. (2016) PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells. Cancer Research, 76(23), pp. 7001-7011. (doi: 10.1158/0008-5472.CAN-16-1134) (PMID:27671680)

Tsim, S. et al. (2016) Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (DIAPHRAGM) study: protocol of a prospective, multi-centre, observational study. BMJ Open, 6(11), e013324. (doi: 10.1136/bmjopen-2016-013324) (PMID:27884852) (PMCID:PMC5168514)

Harrow, S., Hanna, G.G., Faivre-Finn, C., McDonald, F. and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2016) The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer. Clinical Oncology, 28(11), pp. 720-725. (doi: 10.1016/j.clon.2016.08.004) (PMID:27591000)

Lorimer, Cressida F., Saran, Frank, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Brock, Juliet (2016) Glioblastoma in the elderly - how do we choose who to treat? Journal of Geriatric Oncology, 7(6), pp. 453-456. (doi: 10.1016/j.jgo.2016.07.005) (PMID:27478132)

Yahyanejad, S. et al. (2016) NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma. Oncotarget, 7(27), pp. 41251-41264. (doi: 10.18632/oncotarget.9275) (PMID:27183910)

Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2016) Science in focus: combining radiotherapy with inhibitors of the DNA damage response. Clinical Oncology, 28(5), pp. 279-282. (doi: 10.1016/j.clon.2016.01.035) (PMID:26920234)

Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, McGregor, Fiona, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Plumb, Jane (2016) Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer. Oncotarget, 7, 16. (doi: 10.18632/oncotarget.7998) (PMID:26967059) (PMCID:PMC5008389)

Niyazi, M. et al. (2016) ESTRO-ACROP guideline 'target delineation of glioblastomas'. Radiotherapy and Oncology, 118(1), pp. 35-42. (doi: 10.1016/j.radonc.2015.12.003) (PMID:26777122)

2015

Tardito, S. et al. (2015) Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nature Cell Biology, 17(12), pp. 1556-1568. (doi: 10.1038/ncb3272) (PMID:26595383) (PMCID:PMC4663685)

Zmuda, Filip, Malviya, Gaurav ORCID: https://orcid.org/0000-0003-0736-7991, Blair, Adele, Boyd, Marie, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Sutherland, Andrew ORCID: https://orcid.org/0000-0001-7907-5766 and Pimlott, Sally L. ORCID: https://orcid.org/0000-0002-8396-3392 (2015) Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo. Journal of Medicinal Chemistry, 58(21), pp. 8683-8693. (doi: 10.1021/acs.jmedchem.5b01324) (PMID:26469301)

Ahmed, Shafiq, Carruthers, Ross ORCID: https://orcid.org/0000-0003-1077-6120, Gilmour, Lesley, Yildirim, Salih, Watts, Colin and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2015) Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Research, 75(20), pp. 4416-4428. (doi: 10.1158/0008-5472.can-14-3790) (PMID:26282173)

Mac Leod, N. et al. (2015) F-18 FDG PET-CT influences target delineation when combined with standard CT-based radiotherapy planning in the palliative setting in malignant pleural mesothelioma; an exploratory study. Reports of Radiotherapy and Oncology, 2(2), e3999. (doi: 10.17795/rro-3999)

Carruthers, Ross ORCID: https://orcid.org/0000-0003-1077-6120 and Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 (2015) Combination of PARP inhibitors with clinical radiotherapy. In: Curtin, Nicola J. and Sharma, Ricky A. (eds.) PARP Inhibitors for Cancer Therapy. Series: Cancer drug discovery and development, 5 (83). Springer International Publishing, pp. 533-551. ISBN 9783319141503 (doi: 10.1007/978-3-319-14151-0_23)

MacLeod, N. et al. (2015) Is radiotherapy useful for treating pain in mesothelioma?: a phase II trial. Journal of Thoracic Oncology, 10(6), pp. 944-950. (doi: 10.1097/JTO.0000000000000499) (PMID:25654216)

Ichim, G. et al. (2015) Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Molecular Cell, 57(5), pp. 860-872. (doi: 10.1016/j.molcel.2015.01.018) (PMID:25702873) (PMCID:PMC4352766)

Meisenberg, Cornelia, Gilbert, Duncan C., Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278, Haley, Vikki, Gollins, Simon, Ward, Simon E. and El-Khamisy, Sherif F. (2015) Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan. Molecular Cancer Therapeutics, 14(2), pp. 575-585. (doi: 10.1158/1535-7163.MCT-14-0762) (PMID:25522766)

Carruthers, Ross ORCID: https://orcid.org/0000-0003-1077-6120, Ahmed, Shafiq U., Strathdee, Karen, Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, Amoah-Buahin, Evelyn, Watts, Colin and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2015) Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Molecular Oncology, 9(1), pp. 192-203. (doi: 10.1016/j.molonc.2014.08.003)

Blair, Adele, Zmuda, Filip, Malviya, Gaurav ORCID: https://orcid.org/0000-0003-0736-7991, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Dewar, Deborah ORCID: https://orcid.org/0000-0002-8388-2779, Pimlott, Sally L. ORCID: https://orcid.org/0000-0002-8396-3392 and Sutherland, Andrew ORCID: https://orcid.org/0000-0001-7907-5766 (2015) A novel 18F-labelled high affinity agent for PET imaging of the translocator protein. Chemical Science, 6(8), pp. 4772-4777. (doi: 10.1039/C5SC01647A)

2014

Ajaz, M., Jefferies, S., Brazil, L., Watts, C. and Chalmers, A. ORCID: https://orcid.org/0000-0002-1746-7278 (2014) Current and investigational drug strategies for glioblastoma. Clinical Oncology, 26(7), pp. 419-430. (doi: 10.1016/j.clon.2014.03.012)

Mannino, Mariella, Gomez-Roman, Natividad ORCID: https://orcid.org/0000-0002-2325-7517, Hochegger, Helfrid and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2014) Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics. Stem Cell Research, 13(1), pp. 135-143. (doi: 10.1016/j.scr.2014.05.001) (PMID:24879067) (PMCID:PMC4085484)

Yahyanejad, Sanaz, Granton, Patrick V., Lieuwes, Natasja G., Gilmour, Lesley, Dubois, Ludwig, Theys, Jan, Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Verhaegen, Frank and Vooijs, Marc (2014) Complementary use of bioluminescence imaging and contrast-enhanced micro-computed tomography in an orthotopic brain tumor model. Molecular imaging, 13, pp. 1-8. (PMID:25743108)

Smalley, Sarah, Chalmers, Anthony J ORCID: https://orcid.org/0000-0002-1746-7278 and Morley, Simon J (2014) mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells. Molecular Cancer, 13(144), (doi: 10.1186/1476-4598-13-144)

2013

Hellevik, T., Pettersen, I., Berg, V., Bruun, J., Bartnes, K., Busund, T.-L., Chalmers, A. ORCID: https://orcid.org/0000-0002-1746-7278, Bremnes,, R. and Martinez-Zubiaurre, I. (2013) Changes in the secretory profile of NSCLC-associated fibroblasts after ablative radiotherapy: potential impact on angiogenesis and tumor growth. Translational Oncology, 6(1), pp. 66-74. (doi: 10.1593/tlo.12349) (PMID:23418618) (PMCID:PMC3573655)

2012

Alagoz, M., Gilbert, D.C., El-Khamisy, S. and Chalmers, A. ORCID: https://orcid.org/0000-0002-1746-7278 (2012) DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. Current Medicinal Chemistry, 19(23), pp. 3874-3885. (doi: 10.2174/092986712802002590)

Ford, Elizabeth, Catt, Susan, Chalmers, Anthony ORCID: https://orcid.org/0000-0002-1746-7278 and Fallowfield, Lesley (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-Oncology, 14(4), pp. 392-404. (doi: 10.1093/neuonc/nor229)

Gilbert, D.C., Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 and El-Khamisy, S.F. (2012) Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets. British Journal of Cancer, 106(1), pp. 18-24. (doi: 10.1038/bjc.2011.498)

Hellevik, T. et al. (2012) Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced. Radiation Oncology, 7(59), (doi: 10.1186/1748-717X-7-59)

2011

Mannino, Mariella and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2011) Radioresistance of glioma stem cells: Intrinsic characteristic or property of the 'microenvironment-stem cell unit'? Molecular Oncology, 5(4), pp. 374-386. (doi: 10.1016/j.molonc.2011.05.001)

Catt, Susan L., Anderson, John L., Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 and Fallowfield, Lesley J. (2011) A UK-wide survey of follow-up practices for patients with high-grade glioma treated with radical intent. Journal of Evaluation in Clinical Practice, 17(1), pp. 1-6. (doi: 10.1111/j.1365-2753.2009.01292.x)

2010

Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278, Lakshman, Mina, Chan, Norman and Bristow, Robert G. (2010) Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets. Seminars in Radiation Oncology, 20(4), pp. 274-281. (doi: 10.1016/j.semradonc.2010.06.001)

Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2010) Overcoming resistance of glioblastoma to conventional cytotoxic therapies by the addition of PARP inhibitors. Anti-Cancer Agents in Medicinal Chemistry, 10(7), pp. 520-533. (doi: 10.2174/187152010793498627)

Löser, Dana A., Shibata, Atsushi, Shibata, Akiko K., Woodbine, Lisa J., Jeggo, Penny A. and Chalmers, Anthony J. ORCID: https://orcid.org/0000-0002-1746-7278 (2010) Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Molecular Cancer Therapeutics, 9(6), pp. 1775-1787. (doi: 10.1158/1535-7163.MCT-09-1027)

Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2010) Evaluating novel radiation techniques for the treatment of cerebral metastases. British Journal of Radiology, 83(986), pp. 98-100. (doi: 10.1259/bjr/15790337)

2009

Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278, Ruff, E.M., Martindale, C., Lovegrove, N. and Short, S.C. (2009) Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. International Journal of Radiation Oncology, Biology, Physics, 75(5), pp. 1511-1519. (doi: 10.1016/j.ijrobp.2009.07.1703)

Dungey, F.A., Caldecott, K.W. and Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2009) Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Molecular Cancer Therapeutics, 8(8), pp. 2243-2245. (doi: 10.1158/1535-7163.MCT-09-0201)

2008

Dungey, F.A., Löser, D.A. and Chalmers, A.J. ORCID: https://orcid.org/0000-0002-1746-7278 (2008) Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-ribose) polymerase: mechanisms and therapeutic potential. International Journal of Radiation Oncology, Biology, Physics, 72(4), pp. 1188-1197. (doi: 10.1016/j.ijrobp.2008.07.031)

This list was generated on Mon Jun 16 05:22:54 2025 BST.

Jump to: Articles | Book Sections